Note: EPS may not be comparable

Cardlytics (NASDAQ: CDLX) reported Q4 EPS of ($0.18). Revenue for the quarter came in at $39.3 million.

Fourth Quarter 2017 Financial Results

• Total revenue was $39.3 million compared to $36.4 million in the fourth quarter of 2016.
• Cardlytics Direct revenue was $38.8 million, an increase of 22% compared to $31.8 million in the fourth quarter 2016.
• GAAP net loss was $(4.1) million compared to a loss of $(7.0) million in the fourth quarter of 2016.
• GAAP net loss attributable to common stockholders was $(4.4) million, or $(1.26) per share based on 3.50 million weighted-average common shares outstanding, compared to a loss of $(7.3) million, or $(2.82) per share based on 2.58 million weighted-average common shares outstanding in the fourth quarter of 2016.
• Adjusted contribution, a non-GAAP metric, was $16.9 million compared to $15.1 million in the fourth quarter of 2016.
• Adjusted EBITDA, a non-GAAP metric, was $0.5 million compared to a loss of $(0.2) million in the fourth quarter of 2016.
• Non-GAAP net loss was $(2.6) million, or $(0.18) per share based on 14.14 million non-GAAP weighted-average common shares outstanding, compared to a loss of $(4.7) million, or $(0.41) per share based on 11.58 million non-GAAP weighted-average common shares outstanding in the fourth quarter of 2016.

For earnings history and earnings-related data on Cardlytics (CDLX) click here.